MedAvail to Report 2022 Second Quarter Financial Results on August 11, 2022

Rhea-AI Summary

MedAvail Holdings, Inc. (NASDAQ: MDVL) will report its Q2 2022 financial results on August 11, 2022, after market close. A conference call will follow on the same day at 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the live audio webcast on MedAvail’s Investor Relations website, which will also feature an archived version for later replay.

MedAvail specializes in technology-enabled pharmacy services through its MedCenter and home delivery operations, aimed at enhancing patient drug adherence.

Positive

• MedAvail reports financial results for Q2 2022, indicating active financial engagement.
• The company's services focus on improving drug adherence, potentially leading to better health outcomes.

Negative

• None.

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)-- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

About SpotRx

SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.

SOURCE MedAvail Holdings, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005184/en/

Investor Relations

Caroline Paul

Gilmartin Group

ir@medavail.com

Source: MedAvail Holdings Inc.

FAQ

When will MedAvail report its Q2 2022 financial results?

MedAvail will report its Q2 2022 financial results on August 11, 2022.

What time is MedAvail's conference call for financial results?

The conference call will take place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Where can I access the webcast for MedAvail's financial results?

The live audio webcast can be accessed through the Investor Relations section of MedAvail's website.

What is the main focus of MedAvail's business?

MedAvail specializes in technology-enabled pharmacy services, providing in-clinic pharmacy services and home delivery to enhance drug adherence.